William Blair reissued their outperform rating on shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) in a research report released on Tuesday morning. William Blair also issued estimates for K2M Group Holdings’ Q3 2017 earnings at ($0.18) EPS, Q4 2017 earnings at ($0.15) EPS, FY2017 earnings at ($0.80) EPS, Q1 2018 earnings at ($0.20) EPS, Q2 2018 earnings at ($0.14) EPS, Q3 2018 earnings at ($0.10) EPS, Q4 2018 earnings at $0.01 EPS and FY2018 earnings at ($0.43) EPS.
Several other research analysts have also recently commented on the company. Piper Jaffray Companies reiterated an overweight rating and issued a $28.00 price target on shares of K2M Group Holdings in a research note on Tuesday. Wells Fargo & Company cut their price objective on K2M Group Holdings from $28.00 to $23.00 and set an outperform rating on the stock in a research note on Tuesday. UBS AG restated a buy rating and set a $24.00 price objective (down previously from $26.00) on shares of K2M Group Holdings in a research note on Tuesday. ValuEngine cut K2M Group Holdings from a hold rating to a sell rating in a research note on Tuesday. Finally, Needham & Company LLC restated a strong-buy rating and set a $27.00 price objective (down previously from $29.00) on shares of K2M Group Holdings in a research note on Monday. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of Buy and an average price target of $25.60.
K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The business had revenue of $65.70 million for the quarter, compared to analysts’ expectations of $66.26 million. During the same quarter in the previous year, the firm posted ($0.27) earnings per share. The company’s revenue was up 11.0% compared to the same quarter last year.
ILLEGAL ACTIVITY WARNING: “K2M Group Holdings, Inc. (KTWO) Earns Outperform Rating from William Blair” was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://sportsperspectives.com/2017/10/13/k2m-group-holdings-inc-ktwo-earns-outperform-rating-from-william-blair.html.
In other news, CFO Gregory S. Cole sold 39,357 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $23.37, for a total transaction of $919,773.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider John Philip Md Kostuik sold 1,090 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $26,247.20. Following the transaction, the insider now directly owns 201,961 shares of the company’s stock, valued at $4,863,220.88. The disclosure for this sale can be found here. Insiders have sold 44,129 shares of company stock valued at $1,033,644 over the last ninety days. Corporate insiders own 5.80% of the company’s stock.
Several large investors have recently bought and sold shares of KTWO. BNP Paribas Arbitrage SA grew its holdings in shares of K2M Group Holdings by 5,175.3% during the second quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock valued at $109,000 after purchasing an additional 4,399 shares during the last quarter. Legal & General Group Plc grew its holdings in shares of K2M Group Holdings by 9.1% during the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after purchasing an additional 564 shares during the last quarter. Dorsey & Whitney Trust CO LLC bought a new position in shares of K2M Group Holdings during the second quarter valued at approximately $211,000. American International Group Inc. grew its holdings in shares of K2M Group Holdings by 7.1% during the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after purchasing an additional 1,047 shares during the last quarter. Finally, Symphony Asset Management LLC bought a new position in shares of K2M Group Holdings during the second quarter valued at approximately $351,000. 97.86% of the stock is owned by institutional investors.
K2M Group Holdings Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.